*恭喜浙江省农业科学院俞老师在SCI期刊 Environmental Science and Pollution Research(IF:2.914)上成功发表
*恭喜西安理工大学张老师,环境水利专业,文章成功发表在SCI期刊Environmental Science and Pollution Research上,IF2.914
*恭喜山东交通学院谢老师在SCI期刊APPLIED SURFACE SCIENCE(IF5.15)上成功发表
*恭喜华中科技大学黄老师在SCI期刊 ACS Applied Materials & Interfaces(IF8.456)上成功发表
*恭喜中南大学湘雅医院黄医生在Frontiers in Oncology(IF 4.137)上成功发表
*恭喜复旦大学辛博士在SCI期刊 FEBS LETTERS(IF2.675)上成功发表
*恭喜中南大学陈博士在THIN-WALLED STRUCTURESSCI期刊(IF3.488)上成功发表
*恭喜湖南工学院郭老师在SCI期刊SIMULATION MODELLING PRACTICE AND THEORY(IF2.42)上成功发表
*恭喜东华大学闫老师在SCI期刊Advanced Functional Materials(IF 15.621)上成功发表
*恭喜安徽医科大学肖老师在SCI期刊BMC CELL BIOLOGY(IF 3.485)上成功发表
*恭喜四川大学华西医院谢医生在SCI期刊European Heart Journal: Acute Cardiovascular Care(IF 3.734)上成功发表

0591-83301811

周一~周日, 8:00 - 23:00

13107667616

周一~周日, 8:00 - 23:00

service@editideas.cn

随时欢迎您的来信!

2021年最新SCI期刊影响因子查询系统

期刊名称:
ISSN:
期刊研究方向:
IF范围:
中科院分区:
SCI/SCIE:
是否OA期刊:
排列方式:

Journal of Tissue Engineering and Regenerative Medicine 期刊详细信息

基本信息
期刊名称 Journal of Tissue Engineering and Regenerative Medicine
Journal of Tissue Engineering and Regenerative Medicine
期刊ISSN 1932-6254
期刊官方网站 http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%291932-7005
是否OA
出版商 John Wiley and Sons Ltd
出版周期 Bimonthly
始发年份 2007
年文章数 386
最新影响因子 4.323(2021)
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物2区
CELL & TISSUE ENGINEERING 细胞与组织工程3区
CELL BIOLOGY 细胞生物学3区
ENGINEERING, BIOMEDICAL 工程:生物医学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.39 0.913 1.025
Materials Science
Biomaterials
28 / 83 66%
Medicine
Medicine (miscellaneous)
44 / 206 78%
Engineering
Biomedical Engineering
54 / 205 73%
补充信息
自引率 4.80%
H-index 50
SCI收录状况 Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1932-6254%5BISSN%5D
投稿指南
期刊投稿网址 https://mc.manuscriptcentral.com/term
收稿范围
Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs.
The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.
Coverage Includes


Studies on the interactions between cells and constructs are welcome, particularly where they advance our understanding of these processes or provide clear suggestions for improvements to existing systems. Surface modification technologies, their effects on protein adsorption and on cell seeding adhesion and proliferation are of major interest to the journal. Both in vitro and in vivo approaches will be considered, as the journal also aims to focus on in vivo responses to cell-material constructs. Typically, papers presenting the design, development or refinement of biomaterials or scaffolds will only be considered when these have been tested for their ability to support cellular attachment/interaction and/or growth, development and differentiation.
The journal also publishes manuscripts dealing with novel approaches to regenerative medicine that apply some type of controlled/sustained release strategy. Papers dealing with the development of carrier systems, cell encapsulation, release of drugs, growth factors, differentiation agents, and other types of bioactive agents, especially when they apply nanotechnology and/or non-invasive approaches, are particularly welcome. Works on the use of tissue engineering to develop novel drug discovery/testing methodologies and models are also of special interest. A particular emphasis is also to be placed on inductive scaffolds and matrices and on smart systems, including self-assembly materials, which will react to physiological stimuli and will elicit some exact and controllable response of specific cell types.
Research on the use of different cell types and methods for controlling their isolation, expansion and differentiation, and manuscripts describing the effects of manipulating cells, such as by gene therapy, or by supplying proteins, DNA or other biomolecules within the constructs used are also encouraged. Submissions of works on the derivation and maintenance of new stem cell lines and on the development of novel cocktails and serum free media for their culturing are also invited. Manuscripts addressing fundamental issues of stem cell biology, namely those related with stem cell plasticity, potency, clonality, etc., will be considered only if there is some discussion on potential strategies for their application in relevant clinical situations, in cell based therapies or regenerative medicine approaches. Papers on cell transplantation technologies, as well as on the use of stem cells in drug discovery are welcome. Works on relevant regulatory and ethical issues might also be considered.
The journal also focuses on the use of bioreactors for cell seeding, culturing and stimulation of cell differentiation. Papers on the effects of diffusion and mechanical stimulation of stem and progenitor cells are welcome. The design of novel bioreactors, the use of bioreactors for 2D and 3D tissue growth, as well as all production and scale-up aspects related to the use of bioreactors and its effect on the clinical introduction of new technologies will be welcomed. Papers on industrial and patent aspects of tissue engineering and regenerative medicine are also within the scope of the journal.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息
近期成功发表案例展示